RxDoctor Payments Data

James Matthews, NP

Psychiatric/Mental Health · Washington, NCNPI 1669258711

Payments from drug & device makers

$1,752in general payments, 2019–2025

Across 99 payments — averaging $17.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$288
  • AbbVie$244
  • Neurocrine Biosciences, Inc.$222
  • E.r. Squibb & Sons, L.L.C.$212
  • Teva Pharmaceuticals USA, Inc.$210
  • Johnson & Johnson$176
  • plus $400 from 5 others

What the payments were for

  • Food & beverage$1,752100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,752 in reported general payments places this provider in the 75th percentile of 947 psychiatric/mental health providers in North Carolina.

See all psychiatric/mental health providers in North Carolina

Medicare billing

Part B allowed, 2024
$10,634
Medicare patients
58
Services billed
128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate12$45,589
VraylarCariprazine Hcl15$22,565
Fluphenazine Decanoate11$1,194
Olanzapine63$989
Risperidone60$886
Divalproex Sodium ErDivalproex Sodium11$687
Quetiapine Fumarate42$629
Duloxetine Hcl32$625
Benztropine Mesylate43$620
Haloperidol12$504
Quetiapine Fumarate ErQuetiapine Fumarate12$396
Buspirone Hcl17$334
Mirtazapine30$333
Alprazolam42$333
Divalproex Sodium12$296

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$176$45,58912 claims
AbbVieVraylar$244$22,56515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 947 psychiatric/mental health providers in North Carolina.

Other psychiatric/mental health in Washington

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →